Software that can enhance stroke patient outcomes by decreasing detection time and reducing disabilities is the first CE marked device that can help find large vessel occlusions (LVOs).
Six months after a couple of failed Phase III trials, Nuvelo has
reinstated clinical development for its blood clot dissolving drug,
but it will have to go it alone after Bayer decided enough is
enough and pulled out of the collaboration.
Merck & Co has licensed rights to a novel drug for the
treatment of stroke, developed by Japan's Ono Pharmaceutical, in
the hope of developing what would be only the second drug to treat
the disease.
Iceland's deCODE Genetics saw its US-listed shares rise more than
10 per cent yesterday after it reported the discovery of a gene
that appears to play a role in whether people are lean or fat.
Researchers from Icelandic genomics company deCODE Genetics have
discovered the first gene ever linked to ischaemic stroke, raising
the hope that new drugs to treat the condition may be developed.
